The Oncology Issue
Cancer poses one of the greatest medical threats of our time. In this issue, you’ll hear from Bristol Myers Squibb’s team of oncology experts regarding the company’s legacy of innovative research, its landmark collaborations and how patients stand to benefit from both.
Volume 2 | June 02, 2017
The I-O Quest
Exploring the research behind why some people respond to immunotherapy and others do not